Latest Rosuvastatin Stories
NEW YORK, May 5 /PRNewswire-FirstCall/ -- Pfizer's Viagra and AstraZeneca's Nexium took the top-two slots on the new L2 Digital IQ Index for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories, designed to provide an actionable metric to optimize pharmaceutical digital ROI. The ranking, created by think tank L2 in partnership with leading media agency PHD Network, evaluated pharmaceutical brands' digital...
LONDON, April 27 /PRNewswire/ -- CRESTOR(TM) (rosuvastatin) has been approved in nineteen countries within the EU for the prevention of major cardiovascular events in patients who are at high risk* of having a first cardiovascular event.
WALTHAM, Mass., April 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a dyslipidemia drug that is dosed once a week would earn 40 percent patient share in the U.S., according to surveyed U.S.
WILMINGTON, Del. and ABBOTT PARK, Ill., March 30 /PRNewswire-FirstCall/ -- AstraZeneca and Abbott (NYSE: ABT) announced today that the U.S.
Highest approved dose of cholesterol-lowering medication could cause harm to muscles SILVER SPRING, Md., March 19 /PRNewswire-USNewswire/ -- The U.S.
OSAKA, Japan, ATLANTA and ANN ARBOR, Mich., March 2 /PRNewswire/ -- Shionogi & Co., Ltd.
WILMINGTON, Del., Feb.
WILMINGTON, Del., Dec. 15 /PRNewswire-FirstCall/ -- The U.S.
WILMINGTON, Del., Dec. 11 /PRNewswire-FirstCall/ -- Today, the U.S.
ORLANDO, Fla., Nov.
- The parings of haberdine; also, any kind of fragments.